Skip to content
Search

Latest Stories

India Bans 328 Combination Drugs With Immediate Effect

In a blow to domestic and international pharmaceutical producers, the Indian government has prohibited the manufacture, sale or distribution for human use of 328 combination drugs referred to as Fixed Dose Combinations (FDCs) with immediate effect.

It has also restricted the manufacture, sale or distribution of six FDCs subject to certain conditions.


Earlier, the government had, through its notifications published on March 10, 2016, prohibited the manufacture for sale, sale and distribution for human use of 344 FDCs. Soon after the ban, the government had prohibited five more FDCs in addition to the 344 under the same provisions.

However, the ban adversely impacted the drug manufacturer paving a way to question the government’s decision in India’s top court, supreme court. Following legal challenges raised by the drug producers, the supreme court called for a review on the ban by an advisory body.

The advisory board found that, there is no therapeutic justification for the ingredients contained in 328 FDCs and that these FDCs may involve risk to human beings. The board recommended that it is necessary to prohibit the manufacture, sale or distribution of these FDCs in the larger public interest.

With regard to six FDCs, the board recommended that their manufacture, sale and distribution be restricted subject to certain conditions based on their therapeutic justification.

Fifteen FDCs out of the 344 prohibited on March 10, 2016, which were claimed to be manufactured prior to September 21, 1988, have been kept out of the purview of current notifications.

Earlier, an expert committee appointed by the central government had also examined these FDCs and made recommendations in line with those of the board.

The central government considered the recommendations of the expert committee and Drugs Technical Advisory Board, and based on such consideration, it was concluded that it is necessary and expedient in public interest to prohibit the manufacture for sale, sale and distribution for human use of these 328 FDCs in the country. The government has also restricted the manufacture, sale or distribution of six FDCs subject to certain conditions.

More For You

 Biman Bangladesh Airlines

Bangladesh's state-run carrier Biman Bangladesh Airlines is currently reviewing additional proposals from both manufacturers.

iStock

Bangladesh orders 25 Boeing aircraft as part of US tariff deal

Highlights
  • Bangladesh orders 25 Boeing wide-body aircraft, first delivery expected in 2029.
  • Biman Bangladesh Airlines evaluating additional offers from Boeing and Airbus.
  • Deal part of broader US trade agreement reducing tariffs from 37 per cent to 20 per cent.


Bangladesh has ordered 25 wide-body aircraft from Boeing as part of a tariff agreement with the United States, a senior commerce ministry official confirmed on Thursday, whilst the country evaluates competing proposals from European manufacturer Airbus.

"We made a commitment and ordered 25 wide-bodies, and we expect to receive the first one in 2029," official Mahbubur Rahman told AFP. "It's part of the tariff deal with the US."

Keep ReadingShow less